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BRIEF COMMUNICATION
DISCREPANCIES AND CONSEQUENCES OF INDIRECT HEMAGGLUTINATION, INDIRECT 
IMMUNOFLUORESCENCE AND ELISA TESTS FOR THE DIAGNOSIS OF CHAGAS DISEASE
Regina Maia de SOUZA & Vicente AMATO NETO
SUMMARY
Using the indirect hemagglutination (IH), indirect immunofluorescence (IIF) and enzyme linked immunosorbent assay (ELISA) 
tests for the diagnosis of Chagas disease, 4000 serum samples were examined. This study was conducted with different purposes: 
clinical interest, research support and parasitological monitoring of those patients with Chagas disease who were treated with heart 
transplantations. The tests occurred without patient selection and in accordance with the medical requests. The results showed 
discrepancies and brought about several questions, considering the different results that all three methods showed when considered 
together. What was found brought about concerns and we suggest the adoption of different measures, aiming to avoid these mismatches 
in the context of this disease.
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INTRODUCTION
For the diagnosis of Chagas disease, serological tests are widely 
used, particularly regarding the diagnostic of the chronic stage of the 
disease7. For this purpose, several tests are presented as useful and yet 
many others appear with new and better improvements1. Several reasons 
lead to this, such as an attempt to become the gold standard test and the 
ease of implementation, for example.
The indirect hemagglutination (IH), indirect immunofluorescence 
(IIF) and indirect enzyme linked immunosorbent assay (ELISA) 
are included among these techniques as the most commonly used 
approaches, serving different purposes, and they are also used in 
epidemiological surveys, in medical care tasks and in scientific research. 
Since they are applied in essential activities regarding patient care and 
public health, these tests should be thoroughly evaluated from various 
points of view.
We performed the three methods and this resulted in the verification of 
certain characteristics that we consider appropriate to report in this paper.
METHODS
In the “Laboratório de Investigação Médica - Parasitologia Médica 
do Hospital das Clinicas da Faculdade de Medicina da Universidade 
de São Paulo”, which works in conjunction with the ”Laboratório de 
Parasitologia do Instituto de Medicina Tropical de São Paulo”, we 
continuously conduct tests to demonstrate Trypanosoma cruzi antibodies 
using the three methods already mentioned (IH; IIF; ELISA). Without 
any previous selection, we analyzed the results of the last 4000 tests 
carried out in the laboratory routine.
Exam requests arrive at the laboratory from several hospital divisions, 
and include only the patient’s name and request information, without 
any further details about each case in particular. These requests are 
related to clinical interest and research programs for therapeutic support 
regarding heart transplantation in patients with severe cardiomyopathy 
in the chronic stage of the disease, who are no longer eligible for typical 
treatment measures. This help is essential to provide care to those who 
need the information given by the mentioned techniques. That being 
said, we refer ourselves exclusively to the task of providing test results 
to the requesters.
The techniques used were IH, IIF and ELISA, respectively indicated 
by HOSHINO-SHIMIZU et al.4, CAMARGO3 and VOLLER et al.12. The 
details about each technique are described below. 
Indirect Hemagglutination: initial dilution: 1/20 in buffered saline 
solution, kit: CECON - Centro de Controle de Produtos para Diagnósticos 
Ltda. 
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Indirect immunofluorescence: initial dilution: 1/20, in buffered 
saline solution; antigens: epimastigotes of Trypanosoma cruzi isolated 
from culture media (CECON - Centro de Controle de Produtos para 
Diagnósticos Ltda). 
ELISA: serum dilution: 1/201; kit: Hemobio Chagas HBK 401, 
ELISA - (Embrabil - Empresa Brasileira de Biotecnologia SA.); 
absorbance reading: 450nm, in ELISA-LP 400 Microplate Reader.
To characterize positivity, we adopted the following criteria: IH - 
dilution ≥1/40; IIF (IgG) dilution ≥1/40; ELISA - average reading value 
= 2.9278, Cut-off value = 0.325 and grey zone ranging from 0.292 to 
0.57. Doubtful, conflicting, undefined or inconclusive results mean the 
incidence of 1/20 results in one or more tests and/or gray zone results 
in the ELISA test.
We respected the manufacturers´ instructions in our testing.
RESULTS
Results are shown in Tables 1 and 2. The first shows global data and 
the latter includes results calculated according to the individuality of 
the tests, which, along with other findings, raise doubts and questions. 
It is important to remind that the same serum sample was used for all 
three tests. 
COMMENTS
It should be noted that the results show strong heterogeneity that 
resulted from the simultaneous application of three different methods, 
using test kits from the same manufacturer and our constant participation 
in this study. All examined sera were obtained to establish diagnosis, to 
monitor specific treatments, to collaborate on scientific researches and to 
participate in heart transplantation programs, along with other parasitic 
investigations and measures. The Laboratory work served to meet one 
of its purposes: to support other departments from the same institution. 
Of the components of such interests in getting serological reports and 
results, we only received the name and origin of one.
We emphasize that our observations will lie only in what we see in 
these particular cases and in how the tests were conducted, i.e., using 
the three described procedures.
The results found do raise speculation and considerations. The 
diversity found unfortunately must be related with the purposes of those 
who asked for the serological analysis.
As mentioned, the laboratory analyses are related to medical care, 
medical surveys, anti-Trypanosoma cruzi treatment monitoring and 
control and, also, providing support to heart transplantation programs, 
as well as searching for parasites, especially to detect re-activation of 
the infection. The selection of blood donors is equally sought. Risks and 
misinterpretations are acceptable in determining the etiology, whereas 
positivity and negativity rates in these tests are evident.
An epidemiological survey relying only of IH results, for example, 
may reveal a different situation than reality. This applies to the choice 
of tests that, in counterpart, provide inappropriate conclusions. We’ve 
included the selection of blood donors in this reflection, in which case 
a given test may mask what is expected in the correct screening. The 
ELISA test, use of which is officially indicated as preferable, actually 
appeared to reveal discrepancies in our case study.
There is a clear perception that other drawbacks may occur and to 
those, we can add one more: the proof of a large number of dubious 
and unreliable results. They meet the criteria already mentioned and 
cause inconveniences. The laboratory continuously receives requests 
for clarification. 
Several types of matching faults are seen as motivating inconveniences. 
To illustrate, we noticed that when two tests show the same results, either 
positive or negative, a third test, which will complete the set of three, can 
show a different result, affecting the amount of questionable samples. 
According to an attempt to explain the disparities, it is necessary 
to note that IIF detects an specific antibody that reacts with a parasite 
membrane antigen, whereas HI detects an antibody that reacts with 
a subcellular antigen. Each of these serological reactions operates in 
different specificity systems. The antibody indicated by IIF should not 
be the same as that shown by IH. It is evident that the two reactions will 
be positive only when both antibodies are present in the serum. In favor 
of this interpretation is the chronology of positivation following the 
infection by T. cruzi. Of course, the antibodies shown IIF in an early stage 
should not be the same that become positive later by the IH. Still, other 
Table 1
IH, IIF and ELISA behavior - tests performed concurrently.  
Results are displayed according to the number of cases and percentages  
(total = 4000 exams)
Tests Positive Negative Doubtful Percentages (%)
IH, IIF and ELISA 1901 47.5
IH, IIF and ELISA 718 18.0
IH, IIF and ELISA 1381 34.5
IH: indirect hemagglutination; IIF: indirect immunofluorescence; ELISA: Enzyme 
Linked Immunosorbent Assay; Doubtful: 1/20 in one or more tests and/or gray 
zone (ELISA) or in cases of conflicting results.
Table 2
IH, IIF and ELISA: divergent results, calculated emphasizing the tests 
individuality, which, along with other findings, influence the existence of 
dubious results
Tests Positive Negative Percentages (%)
IH only 100 28.3
IIF only 159 45.0
ELISA only 6 1.7
IH only 7 2.0
IIF only 4 1.1
ELISA only 77 21.9
IH: indirect hemagglutination; IIF: indirect immunofluorescence; ELISA: en-
zyme linked immunosorbent assay. The percentages are calculated based on 353 
specified tests.
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observations show that also in the chronic phase of a parasitologically 
confirmed infection, variations in the sensitivity of complement fixation 
tests, IIF and IH may occur. Certainly, an important condition for a 
positive serological reaction is the presence of a sufficient amount of 
antibodies in the serum, so that it can be revealed by the tests in the 
chronic phase of the disease10.
Our findings correspond to a reality. We were not encouraged to 
compare the merits of each test, given how different the casuistry was.
We also emphasize that we were not taking sensitivity and specificity 
evaluation into account in this particular matter. We only showed the 
findings from the tests performed as described in detail which resulted 
in uncomfortable inconsistencies.
We cannot contemplate errors such as the quality of reagents, the 
inexperience of those who performed the tests or the casuistry, keeping 
in mind that the reagents, licensed and approved, were produced by the 
same manufacturer, and the tests were, at all times, performed by two 
competent, accredited and supervised biologists.
We can also wonder whether the change in positivity could eventually 
be related to what we notified in this study. However, it is imperative to 
remember that in our well-stated goal, we do not approach this issue.
The reliability is weakened, requiring attention and possible 
constructive questioning. After all, these uncomfortable perspectives are 
alarming. It has been the subject of considerations, mainly about reagents 
and techniques2,5,6,8,9,10,11. Improvements will be seen when procedures 
with expressive sensitivity will be the choice in routine tasks.
RESUMO
Discordâncias e consequências de resultados de provas de 
hemaglutinação indireta, imunofluorescência indireta e ELISA 
para o diagnóstico da doença de Chagas
Com as provas de hemaglutinação indireta (HI), imunofluorescência 
indireta (IFI) e Enzyme Linked Immunosorbent Assay (ELISA), para 
diagnóstico da doença de Chagas, foram examinadas concomitantemente 
4000 amostras de soro, com diferentes finalidades, tais como interesse 
clínico, apoio a pesquisas e acompanhamento parasitológico de pacientes 
com tal moléstia tratados por meio de transplante de coração. Os testes 
ocorreram, sem seleção e conforme as solicitações, em Laboratório 
que essencialmente prestou colaboração. Os resultados mostraram 
discordâncias, inclusive motivadoras de dúvidas, considerando 
especificamente o revelado pelos três métodos em conjunto. O que ficou 
verificado suscita preocupações e sugere a adoção de medidas aptas a 
evitar essas inadequações no contexto da parasitose.
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